Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2025-12-24 @ 1:21 PM
NCT ID:
NCT01961895
Eligibility Criteria:
Inclusion Criteria:
* Patients with hip fracture within 48 hours of evolution
* Known coronary artery disease:
Previous myocardial infarction Chronic stable angina Atypical angina with positive exercise test for coronary flow failure. Evidence of coronary artery disease with ultrasound, scintigraphic or angiographic compatible
* Patients with at least two of the risk factors for coronary heart disease as defined by Wallace (1998)
Exclusion Criteria:
* Patients receiving orthopedic treatment.
* Patients with coagulopathy, clinic or laboratory.
* Patients with sepsis or infection of the catheter insertion site of lumbar plexus.
* Patients with neurological diseases evolving.
* Patients disoriented, or dementia.
* CKD stage IV National Kidney Foundation (2)
* Glomerular filtration rate between 15 and 29 mL/min/1, 73 m2
* Patients unable to use the Numeric Rating Scale (NRS) to assess pain.
* Patients with non-sinus rhythm or conduction abnormalities (right bundle branch block or left, atrioventricular block) in the admission ECG
* Patients with pacemaker.
* Enrolled patients with acute coronary syndrome or decompensated cardiovascular disease at entry.
* Allergy to any of the drugs of the protocol.
* Inability to understand or unaided sign informed consent.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01961895
Study Brief:
Protocol Section:
NCT01961895